Octopus Molecules, Angewandte Chemie International Edition in English, vol.6, issue.12, pp.814-816, 1974. ,
DOI : 10.1107/S0365110X65002086
"Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies, Synthesis, vol.1978, issue.02, pp.155-158, 1978. ,
DOI : 10.1055/s-1978-24702
Dendritic macromolecules: synthesis of starburst dendrimers, Macromolecules, vol.19, issue.9, pp.2466-2468, 1986. ,
DOI : 10.1021/ma00163a029
Synthesis of Large Dendrimers with the Dimensions of Small Viruses, Journal of the American Chemical Society, vol.135, issue.12, pp.4660-4663, 2013. ,
DOI : 10.1021/ja400432e
Recent Advances in Engineering Polyvalent Biological Interactions, Biomacromolecules, vol.16, issue.1, pp.43-55, 2015. ,
DOI : 10.1021/bm5014469
Multivalent ligand presentation as a central concept to study intricate carbohydrate???protein interactions, Chemical Society Reviews, vol.8, issue.12, pp.3463-3483, 2009. ,
DOI : 10.1002/(SICI)1099-0690(199809)1998:9<1879::AID-EJOC1879>3.0.CO;2-8
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors, Angewandte Chemie International Edition, vol.37, issue.20, pp.2754-2794, 1998. ,
DOI : 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
Influencing Receptor???Ligand Binding Mechanisms with Multivalent Ligand Architecture, Journal of the American Chemical Society, vol.124, issue.50, pp.14922-14933, 2002. ,
DOI : 10.1021/ja027184x
The potential environmental impact of engineered nanomaterials, Nature Biotechnology, vol.21, issue.10, pp.1166-1170, 2003. ,
DOI : 10.1038/nbt875
Do nanomedicines require novel safety assessments to ensure their safety for long-term human use? Drug Saf, pp.625-636, 2009. ,
FDA's Approach to Regulation of Products of Nanotechnology, Science, vol.61, issue.6, pp.299-300 ,
DOI : 10.1016/j.addr.2009.03.006
Next-generation nanomedicines and nanosimilars: EU regulators??? initiatives relating to the development and evaluation of nanomedicines, Nanomedicine, vol.3, issue.5, pp.849-856, 2013. ,
DOI : 10.1007/s11095-010-0233-4
Nanomedicines in the EU???Regulatory Overview, The AAPS Journal, vol.18, issue.6, pp.1576-1582 ,
DOI : 10.1208/s12248-016-9967-1
Available online: http://www.pmda.go.jp/english/rs-sb-std/standards- development/cross-sectional-project/0008, 2017. ,
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine, Chemical Reviews, vol.110, issue.4, pp.1857-1959, 2010. ,
DOI : 10.1021/cr900327d
Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications, Journal of Internal Medicine, vol.5, issue.6, pp.579-617, 2014. ,
DOI : 10.1021/nn2038252
Designing dendrimers for biological applications, Nature Biotechnology, vol.124, issue.12, pp.1517-1526, 2005. ,
DOI : 10.1007/3-540-12796-8_9
Dendrimer Nanovectors for SiRNA Delivery, Methods Mol. Biol, vol.2016, issue.1364, pp.127-142 ,
DOI : 10.1007/978-1-4939-3112-5_11
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications, Drug Discovery Today, vol.15, issue.5-6, pp.171-185, 2010. ,
DOI : 10.1016/j.drudis.2010.01.009
Dendrimer drugs for infection and inflammation, Biochem. Biophys. Res. Commun, vol.2015, issue.468, pp.435-441 ,
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation, Nat. Biotechnol, vol.8, pp.977-984, 2004. ,
Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers, EMBO Molecular Medicine, vol.64, issue.9, pp.866-881, 2012. ,
DOI : 10.1074/jbc.M112.343467
Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers, Journal of Molecular Modeling, vol.42, issue.8, pp.2051-2060, 2011. ,
DOI : 10.1021/ma802154e
URL : https://hal.archives-ouvertes.fr/hal-00652151
Computational design principles for bioactive dendrimer based constructs as antagonists of the TLR4-MD-2-LPS complex, Biomaterials, vol.32, issue.33, pp.8702-8711, 2011. ,
DOI : 10.1016/j.biomaterials.2011.07.085
Partially Glycosylated Dendrimers Block MD-2 and Prevent TLR4-MD-2-LPS Complex Mediated Cytokine Responses, PLoS Computational Biology, vol.457, issue.9, 2011. ,
DOI : 10.1371/journal.pcbi.1002095.s007
Controlling the cytokine storm in severe bacterial diarrhoea with an oral Toll-like receptor 4 antagonist, Immunology, vol.11, issue.2, pp.178-189, 2015. ,
DOI : 10.1016/j.nano.2015.02.018
Unexpected In Vivo Anti-Inflammatory Activity Observed for Simple, Surface Functionalized Poly(amidoamine) Dendrimers, Biomacromolecules, vol.10, issue.5, pp.1195-1202, 2009. ,
DOI : 10.1021/bm9000298
Protective Effects and Mechanisms of G5 PAMAM Dendrimers against Acute Pancreatitis Induced by Caerulein in Mice, Biomacromolecules, vol.16, issue.1, pp.174-182, 2015. ,
DOI : 10.1021/bm501390d
Dendrimer-like PEO Glycopolymers Exhibit Anti-Inflammatory Properties, Journal of the American Chemical Society, vol.127, issue.29, pp.10132-10133, 2005. ,
DOI : 10.1021/ja0511974
URL : https://hal.archives-ouvertes.fr/hal-00394336
Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation, Proc. Natl. Acad. Sci. USA 2010, pp.19679-19684 ,
Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes, Nanoscale, vol.10, issue.42, pp.17672-17684, 2015. ,
DOI : 10.1021/bm9000298
Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer, Journal of Leukocyte Biology, vol.85, issue.3, pp.553-562, 2009. ,
DOI : 10.1189/jlb.0608371
Efficient synthesis of phosphorus-containing dendrimers capped with isosteric functions of amino-bismethylene phosphonic acids, Tetrahedron Letters, vol.50, issue.18, pp.2078-2082, 2009. ,
DOI : 10.1016/j.tetlet.2009.02.127
The key role of the scaffold on the efficiency of dendrimer nanodrugs, Nature Communications, vol.79, pp.2015-7722 ,
DOI : 10.1063/1.445869
Cantagrel, A.; et al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis, Sci. Transl. Med, vol.3, pp.81-116, 2011. ,
Poupot, R.; et al. Frequency and route of administration in the treatment of experimental arthritis by phosphorus-based dendrimer, Ann. Rheum. Dis, p.71, 2012. ,
T Cells, Biomacromolecules, vol.16, issue.11, pp.3425-3433, 2015. ,
DOI : 10.1021/acs.biomac.5b00643
Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent, Arthritis Research & Therapy, vol.16, issue.2, p.98, 2014. ,
DOI : 10.1038/ni1254
Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy, Journal of Translational Medicine, vol.7, issue.1, p.82, 2009. ,
DOI : 10.1186/1479-5876-7-82
URL : https://hal.archives-ouvertes.fr/inserm-00668486
An Azabisphosphonate-Capped Poly(phosphorhydrazone) Dendrimer for the Treatment of Endotoxin-Induced Uveitis, Molecules, vol.133, issue.8, pp.9305-9316, 2013. ,
DOI : 10.1186/1479-5876-7-82
Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment, Proc. Natl. Acad. Sci. USA 2013, pp.8795-8800 ,
DOI : 10.1016/j.tetlet.2009.02.127
URL : https://hal.archives-ouvertes.fr/hal-00994589
In vivo proinflammatory activity of generations 0???3 (G0???G3) polyamidoamine (PAMAM) nanoparticles, Inflammation Research, vol.9, issue.9, pp.745-755, 2016. ,
DOI : 10.1016/j.nano.2012.05.002
URL : https://hal.archives-ouvertes.fr/pasteur-01351122
Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer, Nanotoxicology, vol.7, issue.4, pp.933-941 ,
DOI : 10.1538/expanim.49.97
Evaluation of nanoparticle immunotoxicity, Nature Nanotechnology, vol.173, issue.7, pp.411-414, 2009. ,
DOI : 10.4049/jimmunol.173.5.3148
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials, Br. J. Pharmacol, vol.2014, issue.171, pp.3988-4000 ,